British consumer goods maker Reckitt Benckiser, the world's largest condom manufacturer, is shifting its strategy in India to focus on women and rural consumers for its Durex brand. This change comes as India surpasses China as the most populous nation, despite low contraceptive use. The Indian government estimates only 10%...
Mankind Pharma Acquires Bharat Serums for $1.63 Billion
New Delhi-based Mankind Pharma, known for products such as Manforce, AcneStar, HealthOK among others, announced its acquisition of Bharat Serums and Vaccines Ltd based in Mumbai. The deal is valued at approximately $1.63 billion, (including debt). This move will grant Mankind access to Bharat Serums' portfolio, particularly in women's health...
India to Have Record Number of IPOs in 2024 – [Cloned #76129]
India has seen a significant surge in initial public offerings (IPOs) over the past year, with 2023 hitting a nine-year high of 238 IPOs raising $7.35 billion. Lesser known companies in sectors such as pharmaceutical's Delhi-headquartered Mankind Pharma's listing, have rekindled interest in IPOs by offering steady revenue growth and...
India to Have Record Number of IPOs in 2024
India has seen a significant surge in initial public offerings (IPOs) over the past year, with 2023 hitting a nine-year high of 238 IPOs raising $7.35 billion. This IPO boom shows no signs of slowing down, with 130 new listings and 313 billion rupees raised so far in 2024. Lesser...
AstraZeneca India, Mankind Pharma, Partner for Access to Asthma Meds in India
AstraZeneca Pharma India has entered into an exclusive distribution agreement with New Delhi- based Mankind Pharma for its budesonide and formoterol fumarate dihydrate (inhaled corticosteroid and long-acting beta-agonist combination) brand Symbicort in India. Under the agreement, AstraZeneca will retain intellectual property rights and remain the Marketing Authorization Holder and...